Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anakinra: Efficacy of Anakinra for the Management of Fever During Neutropenia and Mucositis in Patients With Multiple Myeloma Receiving an Autologous Hematopoietic Stem Cell Transplantation After High-dose Melphalan - An RCT

NCT04099901 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04099901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04099901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anakinra: Efficacy of Anakinra for the Management of Fever During Neutropenia and Mucositis in Patients With Multiple Myeloma Receiving an Autologous Hematopoietic Stem Cell Transplantation After High-dose Melphalan - An RCT
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 4, 2019
Completion date
February 26, 2024
Enrollment
88 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma